Back

Impaired adult hippocampal neurogenesis in Alzheimer's disease is mediated by microRNA-132 deficiency and can be restored by microRNA-132 replacement

Salta, E.; Walgrave, H.; Balusu, S.; Vanden Eynden, E.; Snoeck, S.; Craessaerts, K.; Thrupp, N.; Wolfs, L.; Horre, K.; Fourne, Y.; Ronisz, A.; Silajdzic, E.; Callaerts-Vegh, Z.; D Hooge, R.; Thal, D. R.; Zetterberg, H.; Thuret, S.; Fiers, M.; Sala Frigerio, C.; De Strooper, B.

2020-03-13 neuroscience
10.1101/2020.03.12.988709 bioRxiv
Show abstract

SummaryAdult hippocampal neurogenesis (AHN) plays a crucial role in memory processes and is impeded in the brains of Alzheimers disease (AD) patients. However, the molecular mechanisms impacting AHN in AD brain are unknown. Here we identify miR-132, one of the most consistently downregulated microRNAs in AD, as a novel mediator of the AHN deficits in AD. The effects of miR-132 are cell-autonomous and its overexpression is proneurogenic in the adult neurogenic niche in vivo and in human neural stem cells in vitro. miR-132 knockdown in wild-type mice mimics neurogenic deficits in AD mouse brain. Restoring miR-132 levels in mouse models of AD significantly restores AHN and relevant memory deficits. Our findings provide mechanistic insight into the hitherto elusive functional significance of AHN in AD and designate miR-132 replacement as a novel therapeutic strategy to rejuvenate the AD brain and thereby alleviate aspects of memory decline.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.